Report Thumbnail
Product Code QY0912815488QV0
Published Date 2024/7/3
English131 PagesGlobal

Dual Fluorescence Cell Counter - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code QY0912815488QV0◆The Jul 2025 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/7/3
English 131 PagesGlobal

Dual Fluorescence Cell Counter - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030Pharmaceutical_LifeSciense Market



Abstract


Summary

The Dual Fluorescence Cytometer is a major leap forward in automated cell counting and cell viability analysis. Dual fluorescent cell counters give you sensitive and accurate live/dead cell counts regardless of cell type.
The global market for Dual Fluorescence Cell Counter was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Dual Fluorescence Cell Counter was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dual Fluorescence Cell Counter was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Dual Fluorescence Cell Counter was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Dual Fluorescence Cell Counter include Nexcelom, Logos Biosystems, Thermo Fisher Scientific, Bio-Rad, Beckman Coulter, Merck Millipore, Roche, Olympus and ChemoMetec, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dual Fluorescence Cell Counter, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Dual Fluorescence Cell Counter by region & country, by Type, and by Application.
The Dual Fluorescence Cell Counter market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dual Fluorescence Cell Counter.
Market Segmentation
By Company
Nexcelom
Logos Biosystems
Thermo Fisher Scientific
Bio-Rad
Beckman Coulter
Merck Millipore
Roche
Olympus
ChemoMetec
Advanced Instruments
Corning
Oxford Optronix
DeNovix
Countstar (ALIT Life Sciences)
NanoEntek
Segment by Type:
Fully Automatic
Semi-Automatic
Segment by Application
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology
Research Institutes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Dual Fluorescence Cell Counter manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Dual Fluorescence Cell Counter in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Dual Fluorescence Cell Counter in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

  • 1 Market Overview

    • 1.1 Dual Fluorescence Cell Counter Product Introduction
    • 1.2 Global Dual Fluorescence Cell Counter Market Size Forecast
      • 1.2.1 Global Dual Fluorescence Cell Counter Sales Value (2019-2030)
      • 1.2.2 Global Dual Fluorescence Cell Counter Sales Volume (2019-2030)
      • 1.2.3 Global Dual Fluorescence Cell Counter Sales Price (2019-2030)
    • 1.3 Dual Fluorescence Cell Counter Market Trends & Drivers
      • 1.3.1 Dual Fluorescence Cell Counter Industry Trends
      • 1.3.2 Dual Fluorescence Cell Counter Market Drivers & Opportunity
      • 1.3.3 Dual Fluorescence Cell Counter Market Challenges
      • 1.3.4 Dual Fluorescence Cell Counter Market Restraints
    • 1.4 Assumptions and Limitations
    • 1.5 Study Objectives
    • 1.6 Years Considered
  • 2 Competitive Analysis by Company

    • 2.1 Global Dual Fluorescence Cell Counter Players Revenue Ranking (2023)
    • 2.2 Global Dual Fluorescence Cell Counter Revenue by Company (2019-2024)
    • 2.3 Global Dual Fluorescence Cell Counter Players Sales Volume Ranking (2023)
    • 2.4 Global Dual Fluorescence Cell Counter Sales Volume by Company Players (2019-2024)
    • 2.5 Global Dual Fluorescence Cell Counter Average Price by Company (2019-2024)
    • 2.6 Key Manufacturers Dual Fluorescence Cell Counter Manufacturing Base Distribution and Headquarters
    • 2.7 Key Manufacturers Dual Fluorescence Cell Counter Product Offered
    • 2.8 Key Manufacturers Time to Begin Mass Production of Dual Fluorescence Cell Counter
    • 2.9 Dual Fluorescence Cell Counter Market Competitive Analysis
      • 2.9.1 Dual Fluorescence Cell Counter Market Concentration Rate (2019-2024)
      • 2.9.2 Global 5 and 10 Largest Manufacturers by Dual Fluorescence Cell Counter Revenue in 2023
      • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dual Fluorescence Cell Counter as of 2023)
    • 2.10 Mergers & Acquisitions, Expansion
  • 3 Segmentation by Type

    • 3.1 Introduction by Type
      • 3.1.1 Fully Automatic
      • 3.1.2 Semi-Automatic
    • 3.2 Global Dual Fluorescence Cell Counter Sales Value by Type
      • 3.2.1 Global Dual Fluorescence Cell Counter Sales Value by Type (2019 VS 2023 VS 2030)
      • 3.2.2 Global Dual Fluorescence Cell Counter Sales Value, by Type (2019-2030)
      • 3.2.3 Global Dual Fluorescence Cell Counter Sales Value, by Type (%) (2019-2030)
    • 3.3 Global Dual Fluorescence Cell Counter Sales Volume by Type
      • 3.3.1 Global Dual Fluorescence Cell Counter Sales Volume by Type (2019 VS 2023 VS 2030)
      • 3.3.2 Global Dual Fluorescence Cell Counter Sales Volume, by Type (2019-2030)
      • 3.3.3 Global Dual Fluorescence Cell Counter Sales Volume, by Type (%) (2019-2030)
    • 3.4 Global Dual Fluorescence Cell Counter Average Price by Type (2019-2030)
  • 4 Segmentation by Application

    • 4.1 Introduction by Application
      • 4.1.1 Hospitals & Diagnostic Laboratories
      • 4.1.2 Pharmaceutical & Biotechnology
      • 4.1.3 Research Institutes
      • 4.1.4 Others
    • 4.2 Global Dual Fluorescence Cell Counter Sales Value by Application
      • 4.2.1 Global Dual Fluorescence Cell Counter Sales Value by Application (2019 VS 2023 VS 2030)
      • 4.2.2 Global Dual Fluorescence Cell Counter Sales Value, by Application (2019-2030)
      • 4.2.3 Global Dual Fluorescence Cell Counter Sales Value, by Application (%) (2019-2030)
    • 4.3 Global Dual Fluorescence Cell Counter Sales Volume by Application
      • 4.3.1 Global Dual Fluorescence Cell Counter Sales Volume by Application (2019 VS 2023 VS 2030)
      • 4.3.2 Global Dual Fluorescence Cell Counter Sales Volume, by Application (2019-2030)
      • 4.3.3 Global Dual Fluorescence Cell Counter Sales Volume, by Application (%) (2019-2030)
    • 4.4 Global Dual Fluorescence Cell Counter Average Price by Application (2019-2030)
  • 5 Segmentation by Region

    • 5.1 Global Dual Fluorescence Cell Counter Sales Value by Region
      • 5.1.1 Global Dual Fluorescence Cell Counter Sales Value by Region: 2019 VS 2023 VS 2030
      • 5.1.2 Global Dual Fluorescence Cell Counter Sales Value by Region (2019-2024)
      • 5.1.3 Global Dual Fluorescence Cell Counter Sales Value by Region (2025-2030)
      • 5.1.4 Global Dual Fluorescence Cell Counter Sales Value by Region (%), (2019-2030)
    • 5.2 Global Dual Fluorescence Cell Counter Sales Volume by Region
      • 5.2.1 Global Dual Fluorescence Cell Counter Sales Volume by Region: 2019 VS 2023 VS 2030
      • 5.2.2 Global Dual Fluorescence Cell Counter Sales Volume by Region (2019-2024)
      • 5.2.3 Global Dual Fluorescence Cell Counter Sales Volume by Region (2025-2030)
      • 5.2.4 Global Dual Fluorescence Cell Counter Sales Volume by Region (%), (2019-2030)
    • 5.3 Global Dual Fluorescence Cell Counter Average Price by Region (2019-2030)
    • 5.4 North America
      • 5.4.1 North America Dual Fluorescence Cell Counter Sales Value, 2019-2030
      • 5.4.2 North America Dual Fluorescence Cell Counter Sales Value by Country (%), 2023 VS 2030
    • 5.5 Europe
      • 5.5.1 Europe Dual Fluorescence Cell Counter Sales Value, 2019-2030
      • 5.5.2 Europe Dual Fluorescence Cell Counter Sales Value by Country (%), 2023 VS 2030
    • 5.6 Asia Pacific
      • 5.6.1 Asia Pacific Dual Fluorescence Cell Counter Sales Value, 2019-2030
      • 5.6.2 Asia Pacific Dual Fluorescence Cell Counter Sales Value by Country (%), 2023 VS 2030
    • 5.7 South America
      • 5.7.1 South America Dual Fluorescence Cell Counter Sales Value, 2019-2030
      • 5.7.2 South America Dual Fluorescence Cell Counter Sales Value by Country (%), 2023 VS 2030
    • 5.8 Middle East & Africa
      • 5.8.1 Middle East & Africa Dual Fluorescence Cell Counter Sales Value, 2019-2030
      • 5.8.2 Middle East & Africa Dual Fluorescence Cell Counter Sales Value by Country (%), 2023 VS 2030
  • 6 Segmentation by Key Countries/Regions

    • 6.1 Key Countries/Regions Dual Fluorescence Cell Counter Sales Value Growth Trends, 2019 VS 2023 VS 2030
    • 6.2 Key Countries/Regions Dual Fluorescence Cell Counter Sales Value
      • 6.2.1 Key Countries/Regions Dual Fluorescence Cell Counter Sales Value, 2019-2030
      • 6.2.2 Key Countries/Regions Dual Fluorescence Cell Counter Sales Volume, 2019-2030
    • 6.3 United States
      • 6.3.1 United States Dual Fluorescence Cell Counter Sales Value, 2019-2030
      • 6.3.2 United States Dual Fluorescence Cell Counter Sales Value by Type (%), 2023 VS 2030
      • 6.3.3 United States Dual Fluorescence Cell Counter Sales Value by Application, 2023 VS 2030
    • 6.4 Europe
      • 6.4.1 Europe Dual Fluorescence Cell Counter Sales Value, 2019-2030
      • 6.4.2 Europe Dual Fluorescence Cell Counter Sales Value by Type (%), 2023 VS 2030
      • 6.4.3 Europe Dual Fluorescence Cell Counter Sales Value by Application, 2023 VS 2030
    • 6.5 China
      • 6.5.1 China Dual Fluorescence Cell Counter Sales Value, 2019-2030
      • 6.5.2 China Dual Fluorescence Cell Counter Sales Value by Type (%), 2023 VS 2030
      • 6.5.3 China Dual Fluorescence Cell Counter Sales Value by Application, 2023 VS 2030
    • 6.6 Japan
      • 6.6.1 Japan Dual Fluorescence Cell Counter Sales Value, 2019-2030
      • 6.6.2 Japan Dual Fluorescence Cell Counter Sales Value by Type (%), 2023 VS 2030
      • 6.6.3 Japan Dual Fluorescence Cell Counter Sales Value by Application, 2023 VS 2030
    • 6.7 South Korea
      • 6.7.1 South Korea Dual Fluorescence Cell Counter Sales Value, 2019-2030
      • 6.7.2 South Korea Dual Fluorescence Cell Counter Sales Value by Type (%), 2023 VS 2030
      • 6.7.3 South Korea Dual Fluorescence Cell Counter Sales Value by Application, 2023 VS 2030
    • 6.8 Southeast Asia
      • 6.8.1 Southeast Asia Dual Fluorescence Cell Counter Sales Value, 2019-2030
      • 6.8.2 Southeast Asia Dual Fluorescence Cell Counter Sales Value by Type (%), 2023 VS 2030
      • 6.8.3 Southeast Asia Dual Fluorescence Cell Counter Sales Value by Application, 2023 VS 2030
    • 6.9 India
      • 6.9.1 India Dual Fluorescence Cell Counter Sales Value, 2019-2030
      • 6.9.2 India Dual Fluorescence Cell Counter Sales Value by Type (%), 2023 VS 2030
      • 6.9.3 India Dual Fluorescence Cell Counter Sales Value by Application, 2023 VS 2030
  • 7 Company Profiles

    • 7.1 Nexcelom
      • 7.1.1 Nexcelom Company Information
      • 7.1.2 Nexcelom Introduction and Business Overview
      • 7.1.3 Nexcelom Dual Fluorescence Cell Counter Sales, Revenue and Gross Margin (2019-2024)
      • 7.1.4 Nexcelom Dual Fluorescence Cell Counter Product Offerings
      • 7.1.5 Nexcelom Recent Development
    • 7.2 Logos Biosystems
      • 7.2.1 Logos Biosystems Company Information
      • 7.2.2 Logos Biosystems Introduction and Business Overview
      • 7.2.3 Logos Biosystems Dual Fluorescence Cell Counter Sales, Revenue and Gross Margin (2019-2024)
      • 7.2.4 Logos Biosystems Dual Fluorescence Cell Counter Product Offerings
      • 7.2.5 Logos Biosystems Recent Development
    • 7.3 Thermo Fisher Scientific
      • 7.3.1 Thermo Fisher Scientific Company Information
      • 7.3.2 Thermo Fisher Scientific Introduction and Business Overview
      • 7.3.3 Thermo Fisher Scientific Dual Fluorescence Cell Counter Sales, Revenue and Gross Margin (2019-2024)
      • 7.3.4 Thermo Fisher Scientific Dual Fluorescence Cell Counter Product Offerings
      • 7.3.5 Thermo Fisher Scientific Recent Development
    • 7.4 Bio-Rad
      • 7.4.1 Bio-Rad Company Information
      • 7.4.2 Bio-Rad Introduction and Business Overview
      • 7.4.3 Bio-Rad Dual Fluorescence Cell Counter Sales, Revenue and Gross Margin (2019-2024)
      • 7.4.4 Bio-Rad Dual Fluorescence Cell Counter Product Offerings
      • 7.4.5 Bio-Rad Recent Development
    • 7.5 Beckman Coulter
      • 7.5.1 Beckman Coulter Company Information
      • 7.5.2 Beckman Coulter Introduction and Business Overview
      • 7.5.3 Beckman Coulter Dual Fluorescence Cell Counter Sales, Revenue and Gross Margin (2019-2024)
      • 7.5.4 Beckman Coulter Dual Fluorescence Cell Counter Product Offerings
      • 7.5.5 Beckman Coulter Recent Development
    • 7.6 Merck Millipore
      • 7.6.1 Merck Millipore Company Information
      • 7.6.2 Merck Millipore Introduction and Business Overview
      • 7.6.3 Merck Millipore Dual Fluorescence Cell Counter Sales, Revenue and Gross Margin (2019-2024)
      • 7.6.4 Merck Millipore Dual Fluorescence Cell Counter Product Offerings
      • 7.6.5 Merck Millipore Recent Development
    • 7.7 Roche
      • 7.7.1 Roche Company Information
      • 7.7.2 Roche Introduction and Business Overview
      • 7.7.3 Roche Dual Fluorescence Cell Counter Sales, Revenue and Gross Margin (2019-2024)
      • 7.7.4 Roche Dual Fluorescence Cell Counter Product Offerings
      • 7.7.5 Roche Recent Development
    • 7.8 Olympus
      • 7.8.1 Olympus Company Information
      • 7.8.2 Olympus Introduction and Business Overview
      • 7.8.3 Olympus Dual Fluorescence Cell Counter Sales, Revenue and Gross Margin (2019-2024)
      • 7.8.4 Olympus Dual Fluorescence Cell Counter Product Offerings
      • 7.8.5 Olympus Recent Development
    • 7.9 ChemoMetec
      • 7.9.1 ChemoMetec Company Information
      • 7.9.2 ChemoMetec Introduction and Business Overview
      • 7.9.3 ChemoMetec Dual Fluorescence Cell Counter Sales, Revenue and Gross Margin (2019-2024)
      • 7.9.4 ChemoMetec Dual Fluorescence Cell Counter Product Offerings
      • 7.9.5 ChemoMetec Recent Development
    • 7.10 Advanced Instruments
      • 7.10.1 Advanced Instruments Company Information
      • 7.10.2 Advanced Instruments Introduction and Business Overview
      • 7.10.3 Advanced Instruments Dual Fluorescence Cell Counter Sales, Revenue and Gross Margin (2019-2024)
      • 7.10.4 Advanced Instruments Dual Fluorescence Cell Counter Product Offerings
      • 7.10.5 Advanced Instruments Recent Development
    • 7.11 Corning
      • 7.11.1 Corning Company Information
      • 7.11.2 Corning Introduction and Business Overview
      • 7.11.3 Corning Dual Fluorescence Cell Counter Sales, Revenue and Gross Margin (2019-2024)
      • 7.11.4 Corning Dual Fluorescence Cell Counter Product Offerings
      • 7.11.5 Corning Recent Development
    • 7.12 Oxford Optronix
      • 7.12.1 Oxford Optronix Company Information
      • 7.12.2 Oxford Optronix Introduction and Business Overview
      • 7.12.3 Oxford Optronix Dual Fluorescence Cell Counter Sales, Revenue and Gross Margin (2019-2024)
      • 7.12.4 Oxford Optronix Dual Fluorescence Cell Counter Product Offerings
      • 7.12.5 Oxford Optronix Recent Development
    • 7.13 DeNovix
      • 7.13.1 DeNovix Company Information
      • 7.13.2 DeNovix Introduction and Business Overview
      • 7.13.3 DeNovix Dual Fluorescence Cell Counter Sales, Revenue and Gross Margin (2019-2024)
      • 7.13.4 DeNovix Dual Fluorescence Cell Counter Product Offerings
      • 7.13.5 DeNovix Recent Development
    • 7.14 Countstar (ALIT Life Sciences)
      • 7.14.1 Countstar (ALIT Life Sciences) Company Information
      • 7.14.2 Countstar (ALIT Life Sciences) Introduction and Business Overview
      • 7.14.3 Countstar (ALIT Life Sciences) Dual Fluorescence Cell Counter Sales, Revenue and Gross Margin (2019-2024)
      • 7.14.4 Countstar (ALIT Life Sciences) Dual Fluorescence Cell Counter Product Offerings
      • 7.14.5 Countstar (ALIT Life Sciences) Recent Development
    • 7.15 NanoEntek
      • 7.15.1 NanoEntek Company Information
      • 7.15.2 NanoEntek Introduction and Business Overview
      • 7.15.3 NanoEntek Dual Fluorescence Cell Counter Sales, Revenue and Gross Margin (2019-2024)
      • 7.15.4 NanoEntek Dual Fluorescence Cell Counter Product Offerings
      • 7.15.5 NanoEntek Recent Development
  • 8 Industry Chain Analysis

    • 8.1 Dual Fluorescence Cell Counter Industrial Chain
    • 8.2 Dual Fluorescence Cell Counter Upstream Analysis
      • 8.2.1 Key Raw Materials
      • 8.2.2 Raw Materials Key Suppliers
      • 8.2.3 Manufacturing Cost Structure
    • 8.3 Midstream Analysis
    • 8.4 Downstream Analysis (Customers Analysis)
    • 8.5 Sales Model and Sales Channels
      • 8.5.1 Dual Fluorescence Cell Counter Sales Model
      • 8.5.2 Sales Channel
      • 8.5.3 Dual Fluorescence Cell Counter Distributors
  • 9 Research Findings and Conclusion

  • 10 Appendix

    • 10.1 Research Methodology
      • 10.1.1 Methodology/Research Approach
      • 10.1.2 Data Source
    • 10.2 Author Details
    • 10.3 Disclaimer
USD 3,950 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.